World's Best Scientists 2026 revealed!

Overview

Peter van der Meer is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily lies within the field of Medicine, with a particular focus on Cardiology and Cardiovascular Medicine.

Their work spans several subfields, including Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, and Surgery. The main topics of their research cover areas related to heart and cardiovascular health, such as Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, and Chemotherapy-induced cardiotoxicity and mitigation. Additional topics include Cardiac pacing and defibrillation studies, Atrial Fibrillation Management and Outcomes, Cardiac Imaging and Diagnostics, and Diabetes Treatment and Management.

Peter van der Meer has contributed to a number of publications, including key papers such as:

  • Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC., 2021, PubMed
  • 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery, 2022, European Heart Journal
  • Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy, 2024, New England Journal of Medicine
  • Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), 2020, European Journal of Heart Failure
  • Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management, 2020, European Journal of Preventive Cardiology

The frequent co-authors of Peter van der Meer include Rudolf A. de Boer, Dirk J. van Veldhuisen, Marco Metra, Adriaan A. Voors, and B. Daan Westenbrink.

The scientist often publishes in specialized venues such as:

  • European Journal of Heart Failure
  • European Heart Journal
  • European Journal of Preventive Cardiology
  • ESC Heart Failure
  • JACC CardioOncology

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    Piotr Ponikowski;Adriaan A Voors;Stefan D Anker;Héctor Bueno

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • Anemia and Mortality in Heart Failure Patients: A Systematic Review and Meta-Analysis

    Hessel F. Groenveld;James L. Januzzi;Kevin Damman;Jan van Wijngaarden

  • Iron deficiency in chronic heart failure: an international pooled analysis.

    IJsbrand T. Klip;Josep Comin-Colet;Adriaan A. Voors;Piotr Ponikowski

  • Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

    Dirk J. A. Lok;Peter Van Der Meer;Pieta W. Bruggink-André de la Porte;Erik Lipsic

  • Treating oxidative stress in heart failure: past, present and future.

    Atze van der Pol;Atze van der Pol;Wiek H. van Gilst;Adriaan A. Voors;Peter van der Meer

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

    Piotr Ponikowski;Bridget-Anne Kirwan;Bridget-Anne Kirwan;Stefan D Anker;Theresa McDonagh;Theresa McDonagh

  • Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.

    Dirk J. van Veldhuisen;Piotr Ponikowski;Peter van der Meer;Marco Metra

  • Red blood cell distribution width and 1‐year mortality in acute heart failure

    Roland R. J. van Kimmenade;Asim A. Mohammed;Shanmugam Uthamalingam;Peter van der Meer;Peter van der Meer

  • Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial

    Elke S. Hoendermis;Licette C. Y. Liu;Yoran M. Hummel;Peter van der Meer

  • Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy

    Johann Bauersachs;Tobias König;Peter van der Meer;Mark C Petrie

  • Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats With Heart Failure After Myocardial Infarction

    Peter van der Meer;Erik Lipsic;Robert H. Henning;Kristien Boddeus

  • Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension

    Praveen Surendran;Fotios Drenos;Robin Young;Helen Warren

  • MicroRNAs in heart failure: from biomarker to target for therapy

    Eline L. Vegter;Peter van der Meer;Leon J. de Windt;Yigal M. Pinto

  • Heart Failure Stimulates Tumor Growth by Circulating Factors

    Wouter C Meijers;Manuel Maglione;Stephan J L Bakker;Rupert Oberhuber

  • Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function

    Martijn F Hoes;Niels Grote Beverborg;J David Kijlstra;Jeroen Kuipers

  • Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.

    B. Daan Westenbrink;Erik Lipsic;Peter van der Meer;Pirn van der Harst

  • Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council

    Patrizio Lancellotti;Thomas M Suter;Teresa López-Fernández;Maurizio Galderisi

  • Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

    Dirk J. Lok;Sjoukje I. Lok;Pieta W. Bruggink-André de la Porte;Erik Badings

  • Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis

    Beben Benyamin;Tonu Esko;Janina S. Ried;Aparna Radhakrishnan

Frequent Co-Authors

Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Rudolf A. de Boer
Rudolf A. de Boer University Medical Center Groningen
Piotr Ponikowski
Piotr Ponikowski Wrocław Medical University
John G.F. Cleland
John G.F. Cleland University of Glasgow
Pim van der Harst
Pim van der Harst University Medical Center Utrecht
Hans L. Hillege
Hans L. Hillege University Medical Center Groningen
Marco Metra
Marco Metra University of Brescia
Nilesh J. Samani
Nilesh J. Samani University of Leicester
Kenneth Dickstein
Kenneth Dickstein University of Bergen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees can open doors to diverse healthcare careers in the USA, especially for those not pursuing a traditional MD path. For individuals without previous nursing experience, online bsn programs for non nurses provide a flexible entry into registered nursing, allowing you to study and qualify from anywhere.

If you are interested in healthcare administration or support roles, there are also healthcare administration degree programs offered online, which are designed for quick completion and career advancement.

Financial aid is often a critical factor. For students seeking affordable pathways, online medical billing and coding schools that accept fafsa can lower costs and grant access to in-demand medical coding careers.

Additionally, some nursing programs have more accessible admissions. If you’re aiming to become an LPN, finding out do I need to take the TEAS test for LPN can help you identify schools that have streamlined requirements, making your pathway into nursing even smoother.

Best Scientists Citing Peter van der Meer

Trending Scientists